Tocotrienols
Also called: tocotrienol-rich fraction, TRF, alpha-tocotrienol, beta-tocotrienol, gamma-tocotrienol, delta-tocotrienol
Four of the eight naturally occurring forms of vitamin E (alpha-, beta-, gamma- and delta-tocotrienol). Products include palm-oil tocotrienol-rich fraction (TRF) and annatto-seed tocotrienols. Official vitamin E recommendations cover alpha-tocopherol only.
- Category
- Vitamin
- Forms
- Tocotrienol-rich fraction (TRF) from palm oil; tocotrienols from annatto seed oil (Bixa orellana); delta-tocotrienol
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2025 systematic review identified 30 RCTs (2,646 patients) of palm tocotrienol-rich fraction published through 2022. [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels1 topic
CLiver1 topic
CImmune system and infection1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| HbA1c, blood pressure and CRP in type 2 diabetes | B | A 2023 meta-analysis of 10 RCTs found tocotrienol-rich fraction (250-400 mg) lowered HbA1c (-0.23; n = 754) but did not lower systolic or diastolic blood pressure or hs-CRP. [3] |
| Inflammation and oxidative-stress markers | C | A 2021 meta-analysis (19 RCTs reviewed, 13 pooled) found lower CRP, attributed to a single delta-tocotrienol study, and no effect on IL-6, TNF-alpha or malondialdehyde. [4] |
| Liver markers in nonalcoholic fatty liver disease | C | A 24-week RCT (71 patients; delta-tocotrienol 300 mg twice daily) reduced fatty liver index, HOMA-IR, hs-CRP, ALT, AST and ultrasound steatosis grade versus placebo. [5] |
Main constituents: Alpha-, beta-, gamma- and delta-tocotrienol [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Tocotrienol-rich fraction 250-400 mg in type 2 diabetes trials. [3]
- Delta-tocotrienol 300 mg twice daily for 24 weeks. [5]
Upper limits
- ODS: the Food and Nutrition Board's vitamin E recommendations are for alpha-tocopherol alone; the adult UL of 1,000 mg for supplemental vitamin E applies to all forms of supplemental alpha-tocopherol. [1]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications1 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- In the 24-week NAFLD trial of delta-tocotrienol (600 mg/day), no adverse events were reported. [5]
Regulatory status
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Alpha-, beta-, gamma- and delta-tocotrienol Vitamin E forms (tocotrienols) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 1 entry naming tocotrienols: tocotrienols from annatto seed oil (Bixa orellana) (NDI 1369 submitted 2024-10-31). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
- Looi et al. (2025): tocotrienol-rich fraction is abundant in palm oil. [P6]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
- NIH Office of Dietary Supplements. Vitamin E: Fact Sheet for Health Professionals (Updated: October 19, 2026), 2026-10-19. ods.od.nih.gov
- Looi AD, et al. Health benefits of palm tocotrienol-rich fraction: a systematic review of randomized controlled trials. Nutr Rev 2025;83(2):307-328 (PMID 38916919), 2025-02-01. pubmed.ncbi.nlm.nih.gov
Sources
- NIH Office of Dietary Supplements. Vitamin E: Fact Sheet for Health Professionals (Updated: October 19, 2026), 2026-10-19. ods.od.nih.gov
- Looi AD, et al. Health benefits of palm tocotrienol-rich fraction: a systematic review of randomized controlled trials. Nutr Rev 2025;83(2):307-328 (PMID 38916919), 2025-02-01. pubmed.ncbi.nlm.nih.gov
- Phang SCW, et al. Effects of tocotrienol-rich fraction supplementation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr 2023;14(5):1159-1169 (PMID 37321474), 2023-09. pubmed.ncbi.nlm.nih.gov
- Khor BH, et al. Effects of tocotrienols supplementation on markers of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2021;16(7):e0255205 (PMID 34297765), 2021-07-23. pubmed.ncbi.nlm.nih.gov
- Pervez MA, et al. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. Complement Ther Med 2020;52:102494 (PMID 32951743), 2020-08. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in vitamin: Benfotiamine · Biotin · Folate (folic acid) · Methylfolate (L-5-MTHF) · Niacin (vitamin B3) · Nicotinamide riboside · Pantothenic acid (vitamin B5) · Riboflavin (vitamin B2) · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.